Measuring malaria diagnosis and treatment coverage in population-based surveys: a recall validation study in Mali among caregivers of febrile children under 5 years.
Antimalarials
/ therapeutic use
Artemisinins
/ therapeutic use
Caregivers
Case-Control Studies
Child, Preschool
Drug Therapy, Combination
Family Characteristics
Female
Fever
/ epidemiology
Humans
Infant
Malaria
/ diagnosis
Male
Mali
Mental Recall
Patient Acceptance of Health Care
Prospective Studies
Rural Health Services
Sensitivity and Specificity
Surveys and Questionnaires
Urban Health Services
Artemisinin-based combination therapy
Malaria
Population survey
Recall validation
Journal
Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802
Informations de publication
Date de publication:
03 Jan 2019
03 Jan 2019
Historique:
received:
27
08
2018
accepted:
24
12
2018
entrez:
4
1
2019
pubmed:
4
1
2019
medline:
12
2
2019
Statut:
epublish
Résumé
Nationally-representative household surveys are the standard approach to monitor access to and treatment with artemisinin-based combination therapy (ACT) among children under 5 years (U5), however these indicators are dependent on caregivers' recall of the treatment received. A prospective case-control study was performed in Mali to validate caregivers' recall of treatment received by U5s when seeking care for fever from rural and urban public health facilities, community health workers and urban private facilities. Clinician-recorded consultation details were the gold standard. Consenting caregivers were followed-up for interview at home within 2 weeks using standard questions from Demographic and Health Surveys and Malaria Indicator Surveys. Among 1602 caregivers, sensitivity of recalling that the child received a finger/heel prick was 91.5%, with specificity 85.7%. Caregivers' recall of a positive malaria test result had sensitivity 96.2% with specificity 59.7%. Irrespective of diagnostic test result, the sensitivity and specificity of caregivers' recalling a malaria diagnosis made by the health worker were 74.3% and 74.9%, respectively. Caregivers' recall of ACT being given had sensitivity of 43.2% and specificity 90.2%, while recall that any anti-malarial was given had sensitivity 59.0% and specificity 82.7%. Correcting caregivers' response of treatment received using a combination of a visual aid with photographs of common drugs for fever, prescription documents and retained packaging changed ACT recall sensitivity and specificity to 91.5% and 71.1%, respectively. These findings indicate that caregivers' responses during household surveys are valid when assessing if a child received a finger/heel prick during a consultation in the previous 2 weeks, and if the malaria test result was positive. Recall of ACT treatment received by U5s was poor when based on interview response only, but was substantially improved when incorporating visual aids, prescriptions and drug packaging review.
Sections du résumé
BACKGROUND
BACKGROUND
Nationally-representative household surveys are the standard approach to monitor access to and treatment with artemisinin-based combination therapy (ACT) among children under 5 years (U5), however these indicators are dependent on caregivers' recall of the treatment received.
METHODS
METHODS
A prospective case-control study was performed in Mali to validate caregivers' recall of treatment received by U5s when seeking care for fever from rural and urban public health facilities, community health workers and urban private facilities. Clinician-recorded consultation details were the gold standard. Consenting caregivers were followed-up for interview at home within 2 weeks using standard questions from Demographic and Health Surveys and Malaria Indicator Surveys.
RESULTS
RESULTS
Among 1602 caregivers, sensitivity of recalling that the child received a finger/heel prick was 91.5%, with specificity 85.7%. Caregivers' recall of a positive malaria test result had sensitivity 96.2% with specificity 59.7%. Irrespective of diagnostic test result, the sensitivity and specificity of caregivers' recalling a malaria diagnosis made by the health worker were 74.3% and 74.9%, respectively. Caregivers' recall of ACT being given had sensitivity of 43.2% and specificity 90.2%, while recall that any anti-malarial was given had sensitivity 59.0% and specificity 82.7%. Correcting caregivers' response of treatment received using a combination of a visual aid with photographs of common drugs for fever, prescription documents and retained packaging changed ACT recall sensitivity and specificity to 91.5% and 71.1%, respectively.
CONCLUSIONS
CONCLUSIONS
These findings indicate that caregivers' responses during household surveys are valid when assessing if a child received a finger/heel prick during a consultation in the previous 2 weeks, and if the malaria test result was positive. Recall of ACT treatment received by U5s was poor when based on interview response only, but was substantially improved when incorporating visual aids, prescriptions and drug packaging review.
Identifiants
pubmed: 30602376
doi: 10.1186/s12936-018-2636-3
pii: 10.1186/s12936-018-2636-3
pmc: PMC6317217
doi:
Substances chimiques
Antimalarials
0
Artemisinins
0
Types de publication
Journal Article
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
3Subventions
Organisme : United States Agency for International Development
ID : AIDOAA-L-14-00004
Organisme : United States Agency for International Development
ID : AIDOAA-C-13-00095
Références
Biometrics. 2000 Jun;56(2):645-6
pubmed: 10877330
Trop Med Int Health. 2006 Oct;11(10):1613-24
pubmed: 17002736
Health Policy Plan. 2006 Nov;21(6):459-68
pubmed: 17030551
Malar J. 2007 May 16;6:58
pubmed: 17506881
Malar J. 2008 Jan 29;7:25
pubmed: 18230140
Malar J. 2008 Oct 29;7:221
pubmed: 18959777
PLoS Med. 2013;10(5):e1001417
pubmed: 23667337
PLoS Med. 2013;10(5):e1001421
pubmed: 23667338
PLoS Med. 2013;10(5):e1001423
pubmed: 23667340
PLoS One. 2013 Nov 07;8(11):e79943
pubmed: 24244581
Malar J. 2014 Jan 06;13:7
pubmed: 24386988
Malar J. 2016 Mar 12;15:158
pubmed: 26968167
PLoS One. 2016 Aug 05;11(8):e0160008
pubmed: 27494250
PLoS One. 2016 Aug 05;11(8):e0159525
pubmed: 27494507
Lancet Glob Health. 2017 Apr;5(4):e418-e427
pubmed: 28288746
Malar J. 2017 May 19;16(1):205
pubmed: 28526075
Malar J. 2017 Aug 10;16(1):325
pubmed: 28797263
J Glob Health. 2018 Dec;8(2):020804
pubmed: 30202519